Andrew Gray, Ph.D.
Affiliations: | 2011 | Genetic, Molecular, and Cell Biology | University of Southern California, Los Angeles, CA, United States |
Area:
Immunology, Oncology, Cell BiologyGoogle:
"Andrew Gray"Parents
Sign in to add mentor| W Martin Kast | grad student | 2011 | USC | |
| (The effect of tumor-mediated immune suppression on prostate cancer immunotherapy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Yan L, Silva DM, Verma B, et al. (2015) Forced LIGHT expression in prostate tumors overcomes Treg mediated immunosuppression and synergizes with a prostate tumor therapeutic vaccine by recruiting effector T lymphocytes. The Prostate. 75: 280-91 |
| Gray A, Yan L, Kast WM. (2010) Prevention is better than cure: the case for clinical trials of therapeutic cancer vaccines in the prophylactic setting. Molecular Interventions. 10: 197-203 |
| Gray A, de la Luz Garcia-Hernandez M, van West M, et al. (2009) Prostate cancer immunotherapy yields superior long-term survival in TRAMP mice when administered at an early stage of carcinogenesis prior to the establishment of tumor-associated immunosuppression at later stages. Vaccine. 27: G52-9 |
| Koh YT, Gray A, Higgins SA, et al. (2009) Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization. The Prostate. 69: 571-84 |
| Raff AB, Gray A, Kast WM. (2009) Prostate stem cell antigen: a prospective therapeutic and diagnostic target. Cancer Letters. 277: 126-32 |
| Gray A, Raff AB, Chiriva-Internati M, et al. (2008) A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting. Immunological Reviews. 222: 316-27 |
| Garcia-Hernandez Mde L, Gray A, Hubby B, et al. (2008) Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity. Cancer Research. 68: 861-9 |
| Garcia-Hernandez Mde L, Gray A, Hubby B, et al. (2007) In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate: a candidate antigen for treating prostate cancer. Cancer Research. 67: 1344-51 |